Alx Oncology Holdings Inc (ALXO)

Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	4.92%18.03	18.97	23.02	22.53	26.65
Research and Development	3.44%13.14	13.61	17.65	17.44	18.02
Interest Income/Expense	13.90%0.29	0.33	0.38	0.41	0.41
Depreciation and Amortization	0.10	0.10	0.10	0.20	0.20
Operating Income/Loss	4.92%-18.03	-18.97	-23.02	-22.53	-26.65
	0.25%-17.97	-17.93	-22.85	-22.14	-25.95
Attributable To Parent	0.25%-17.97	-17.93	-22.85	-22.14	-25.95
Basic Average Shares	29.71%135.64	104.57	0.21	53.58	53.45
Diluted Average Shares	29.71%135.64	104.57	0.21	53.58	53.45
Basic Earnings Per Share	23.53%-0.13	-0.17	-0.42	-0.41	-0.49
Diluted Earnings Per Share	23.53%-0.13	-0.17	-0.42	-0.41	-0.49